BIOTRONIK and GenesisCare Partner to Improve Heart Disease Therapy
Global Medical Device Company and Leader in Cardiology Care Pool Their Health Care Expertise in Australia
Today BIOTRONIK and GenesisCare started a three-year strategic partnership to enhance outcomes for cardiac patients in Australia. The new partners will initiate interdisciplinary research projects focusing on better data sharing, care pathways and integration, as well as tracking outcomes.
“With the necessary technology and know-how, we aim to improve patient outcomes with more responsive, personalized and appropriate care,” explained Dr. Stephen Worthley, Executive Manager at GenesisCare. “This could lead to fewer adverse events, earlier detection of preventable problems and reduced need for hospitalization.”
Cardiac patients can benefit from this new approach in terms of fewer hospital visits and complications, and lower mortality. This ultimately translates into lower therapy costs, benefiting patients and health insurers.
“Our partnership aims to overcome obstacles we face when acting alone,” commented Jan Ewert, Managing Director of BIOTRONIK Australia and New Zealand. “We look forward to collaborating with GenesisCare to work towards a common goal: redefining how patients receive the best possible care.”
GenesisCare comprises the largest group of private practice cardiologists in Australia. The company has established systems to monitor and measure patient outcomes. BIOTRONIK, a global producer of cardio- and endovascular medical products, will contribute its vast technological knowledge to the partnership.
BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.